Home Other Building Blocks 3-Methylsalicylic acid

3-Methylsalicylic acid

CAS No.:
83-40-9
Catalog Number:
AG0035U1
Molecular Formula:
C8H8O3
Molecular Weight:
152.1473
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
98%
In Stock USA
United States
$13
- +
25g
98%
In Stock USA
United States
$19
- +
100g
98%
In Stock USA
United States
$50
- +
500g
98%
In Stock USA
United States
$188
- +
Product Description
Catalog Number:
AG0035U1
Chemical Name:
3-Methylsalicylic acid
CAS Number:
83-40-9
Molecular Formula:
C8H8O3
Molecular Weight:
152.1473
MDL Number:
MFCD00002448
IUPAC Name:
2-hydroxy-3-methylbenzoic acid
InChI:
InChI=1S/C8H8O3/c1-5-3-2-4-6(7(5)9)8(10)11/h2-4,9H,1H3,(H,10,11)
InChI Key:
WHSXTWFYRGOBGO-UHFFFAOYSA-N
SMILES:
OC(=O)c1cccc(c1O)C
EC Number:
201-473-8
UNII:
ZH3HEY032H
Properties
Complexity:
155  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
152.047g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
152.149g/mol
Monoisotopic Mass:
152.047g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
57.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.9  
Literature
Title Journal
Identifying chelators for metalloprotein inhibitors using a fragment-based approach. Journal of medicinal chemistry 20110127
The concept of 'compartment allergy': prilocaine injected into different skin layers. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 20110101
Photophysical properties of lanthanide hybrids covalently bonded to functionalized MCM-41 by modified aromatic carboxylic acids. Journal of fluorescence 20090301
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II. Bioorganic & medicinal chemistry 20081015
Gene expression-based screening for inhibitors of PDGFR signaling. Genome biology 20080101
Mechanisms influencing the vasoactive effects of lidocaine in human skin. Anaesthesia 20070201
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Enhanced skin permeation of salicylate by ion-pair formation in non-aqueous vehicle and further enhancement by ethanol and l-menthol. Chemical & pharmaceutical bulletin 20060401
Synthesis and characterisation of tungsten(VI) oxo-salicylate complexes for use in the chemical vapour deposition of self-cleaning films. Dalton transactions (Cambridge, England : 2003) 20050407
Construction and evaluation of nagR-nagAa::lux fusion strains in biosensing for salicylic acid derivatives. Applied biochemistry and biotechnology 20050301
[Anti-inflammatory activity of (o-cresotinate) copper and zinc aquacomplexes]. Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti 20020701
Substituted alkyne synthesis under nonbasic conditions: copper carboxylate-mediated, palladium-catalyzed thioalkyne-boronic acid cross-coupling. Organic letters 20010111
Properties